Beavis K G, Lichty M B, Jungkind D L, Giger O
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
J Clin Microbiol. 1995 Oct;33(10):2582-6. doi: 10.1128/jcm.33.10.2582-2586.1995.
We evaluated the Amplicor PCR assay (Roche Molecular Systems, Branchburg, N.J.) for direct detection of Mycobacterium tuberculosis in sputum. A total of 532 specimens from 270 patients were decontaminated and stored at 4 or -75 degrees C until assayed by PCR. This assay used three-step sample preparation, biotinylated primer pairs, AmpErase, and a microtiter format for amplicon capture and detection. Amplicor PCR results were compared with clinical history, culture from a Lowenstein-Jensen slant, and results from the BACTEC TB-460 system. Eighty-seven cultures from 15 patients grew M. tuberculosis; of these, 83 (95%) were positive with the Amplicor PCR test. The false negatives were most likely due to sample variation and inhibitors. Of the 445 specimens from which M. tuberculosis was not isolated, 428 (96%) were negative with the Amplicor PCR test. Of the 17 M. tuberculosis culture-negative, Amplicor-positive specimens, 15 were reclassified as true positives because previous cultures grew M. tuberculosis. Of the 445 specimens which did not grow M. tuberculosis, Mycobacterium spp. other than M. tuberculosis were isolated from 150 specimens. Three of these 150 specimens were Amplicor positive; two were from a patient with a history of tuberculosis, and one specimen gave a false-positive result. We do not feel that this represents cross-reactivity, because repeated Amplicor testing of the isolate gave negative results. The microtiter plate has 96 wells. Allowing for six controls, 90 decontaminated specimens can be tested by one technologist in 7.5 h. This PCR assay took 7.5 h to complete and is a sensitive and specific, rapid method for the direct detection of M. tuberculosis from sputum.
我们评估了用于直接检测痰液中结核分枝杆菌的Amplicor聚合酶链反应(PCR)检测法(罗氏分子系统公司,新泽西州布兰奇堡)。来自270名患者的总共532份标本经过去污处理后,保存在4℃或-75℃,直至通过PCR检测。该检测法采用三步样品制备、生物素化引物对、AmpErase以及用于扩增产物捕获和检测的微量滴定板形式。将Amplicor PCR检测结果与临床病史、罗-琴斜面培养结果以及BACTEC TB-460系统的结果进行比较。15名患者的87份培养物中培养出结核分枝杆菌;其中,83份(95%)通过Amplicor PCR检测呈阳性。假阴性很可能是由于样品差异和抑制剂所致。在未分离出结核分枝杆菌的445份标本中,428份(96%)通过Amplicor PCR检测呈阴性。在17份结核分枝杆菌培养阴性但Amplicor检测阳性的标本中,15份被重新分类为真阳性,因为之前的培养物中培养出了结核分枝杆菌。在未培养出结核分枝杆菌的445份标本中,从150份标本中分离出了非结核分枝杆菌的分枝杆菌属。这150份标本中有3份Amplicor检测呈阳性;2份来自有结核病病史的患者,1份标本出现假阳性结果。我们认为这并不代表交叉反应,因为对该分离株进行重复的Amplicor检测结果为阴性。微量滴定板有96个孔。留出6个对照,一名技术人员在7.5小时内可检测90份去污后的标本。该PCR检测法需要7.5小时完成,是一种从痰液中直接检测结核分枝杆菌的灵敏、特异且快速的方法。